ocrelizumab
RxNorm concept 1876366, ingredient (in).
- RxCUI
- 1876366
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1876366 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Ocrevus (BN, has tradename)
- Ocrevus Zunovo (BN, has tradename)
- ocrelizumab 30 MG/ML (SCDC, ingredient of)
- ocrelizumab Injectable Product (SCDG, ingredient of)
- ocrelizumab Injection (SCDF, ingredient of)
- ocrelizumab-ocsq 40 MG/ML (SCDC, ingredient of)
- hyaluronidase / ocrelizumab Injectable Product (SCDG, ingredient of)
- hyaluronidase / ocrelizumab Injection (SCDF, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1876366 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1876366 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1876366. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.